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Abstract p120GAP (RasGAP) has been proposed to function as
both an inhibitor and effector of Ras. Previously we have shown
that RasGAP contains a C2 domain which mediates both Ca2+-
dependent membrane association and protein^protein interac-
tions. Specifically, three proteins have been isolated in a complex
with the C2 domain of RasGAP; these are the Ca2+-dependent
lipid binding protein annexin VI (p70) and two previously
unidentified proteins, p55 and p120. Here we provide evidence
that p55 is the Src family kinase Fyn and p120 is the focal
adhesion kinase family member Pyk2. In addition, in vitro
binding assays indicate that Fyn, but not Pyk2 binds directly to
annexin VI. Finally, co-immunoprecipitation studies in Rat-1
fibroblasts confirm that Fyn, Pyk2, annexin VI and RasGAP can
form a protein complex in mammalian cells.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
p21ras proteins play an important role in cellular prolifer-
ation and di¡erentiation processes [1,2]. They transduce sig-
nals between receptor tyrosine kinases [3], (Gi/Gq) G protein
coupled receptors [4] or src non-receptor tyrosine kinases [5]
and downstream e¡ectors including raf and phosphatidylino-
sitol 3-kinases [6]. In common with all guanine nucleotide
binding proteins, the biological activity of Ras proteins is de-
pendent on the GTP/GDP bound state in which they reside
[7]. This in turn is regulated by guanine nucleotide exchange
factors and GTPase activating proteins (GAPs) respectively.
A number of Ras selective GAPs have been identi¢ed [8^11]
and primary sequence analysis indicates that many members
display sequence similarity both within their GTPase activa-
tion domains (known as the GAP related domain or GRD)
and also within a non-catalytic region called the C2 domain
[8^12]. One such GAP which contains one copy of a C2 do-
main and is an important regulator of Ras activity is the
p120GAP (RasGAP).
C2 (conserved region 2) domains were originally identi¢ed
in protein kinase C isoforms which become activated and
membrane associated in response to Ca2 elevation [13]. C2-
like domains have also been identi¢ed in a wide range of
Ca2-responsive proteins with vastly diverse cellular signalling
functions [14]. The precise function of C2 domains remains
unclear. However, we [15,16] and others [17,18] have demon-
strated that C2 domains may function to direct protein^phos-
pholipid and protein^cellular membrane interactions. In the
case of p120GAP, we have demonstrated that the C2 domain is
important for its translocation from the cytoplasm to a mem-
brane associated location in response to Ca2 elevation [16].
However, many proteins contain two non-identical C2-like
domains [9^11,19,20] and it is thus possible that C2 domains
function only to direct membrane association events. It is,
however, probable that C2 domains can function to mediate
speci¢c protein^protein interactions.
We have recently shown that RasGAP mediates a protein
complex formation with three proteins [21]. We have identi-
¢ed one of these proteins, annexin VI, as interacting directly
with the RasGAP C2-like domain and we have puri¢ed the
other two proteins which form a protein complex with annex-
in VI and RasGAP. These proteins have estimated molecular
weights of approximately 55 and 120 kDa, but so far their
identities have remained undetermined [21]. In this study we
have attempted to identify these proteins in order to gain clues
for any further potential cellular signalling roles that RasGAP
and annexin VI may play.
2. Materials and methods
2.1. Materials
Unless otherwise stated, all reagents were of analytical grade. Re-
striction endonucleases were purchased from New England Biolabs
Inc. (Herts, UK). Glutathione, glutathione-agarose beads, anti-GST
(glutathione S-transferase) antibodies, thrombin, X-Omat Kodak X-
ray ¢lm were purchased from Sigma. pGEX expression system was
purchased from Pharmacia. Tissue culture media and supplements
were purchased from Gibco BRL. Oligonucleotides for fusion protein
construction and sequencing were synthesised by Genosys Biotech
(Europe) Ltd.
Anti-rabbit horseradish peroxidase (HRP)-conjugated secondary
antibodies and SDS^PAGE molecular weight markers were purchased
from Bio-Rad. Rabbit anti-Fyn polyclonal antibodies, anti-myc, anti-
Pyk2, anti-GAP and mouse anti-Fyn monoclonal antibodies were
purchased from UBI. Anti-annexin VI antibodies were prepared as
previously described [21]. The Marathon-Ready human brain cDNA
library was purchased from Clontech laboratories Ltd. pCMV-Tag1
vector was purchased from Stratagene.
2.2. Immunoprecipitation studies
COS-1 cells and Rat-1 ¢broblasts were grown as previously de-
scribed [21]. Unless otherwise stated, cells were routinely used when
they were 80^90% con£uent. Cells were lysed and immunoprecipita-
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tion samples were prepared using anti-Fyn polyclonal, anti-Pyk2, anti-
GAP and mouse anti-Fyn antibodies as previously described [21].
2.3. Western blot detection of complexing proteins in cell lysates
Following SDS^PAGE resolution, proteins were Western trans-
ferred to nitrocellulose and membranes were blocked with 5% (w/v)
skimmed milk. Blots were then probed by their incubation overnight
at 4‡C with either rabbit anti-Pyk2 (1 Wg/ml), anti-GAP (1 Wg/ml),
anti-Fyn antibodies (2 Wg/ml), or anti-annexin VI (1/1000 v/v dilution)
antibodies. Bound antibodies were detected by incubation for 1 h with
goat anti-rabbit HRP-conjugated secondary antibodies diluted 1/3000.
Detection of secondary antibody binding was made using enhanced
chemiluminescence (ECL) followed by visualisation on X-Omat AR
grey ¢lm.
2.4. Construction of GST-Fyn
Human Fyn cDNA was isolated by ¢rst round PCR ampli¢cation
using a Marathon-Ready human brain cDNA library as template
and oligonucleotide primers: 5P-ATGGGCTGTGTGCAATGTAA-
GGAT-3P and 5P-CTCGAATGCTTCACAGAGGAGGTT-3P. The
PCR product obtained was then re-ampli¢ed using primers containing
BamHI and EcoRI restriction endonuclease sites: 5P-TGATGAT-
GAGGATCCATGGGCTGTGTGCAATGTAAGGAT-3P and 5P-
TGATGATGAGAATTCCTCGAATGCTTCACAGAGGAGGTT-3P.
This second round PCR ampli¢ed fragment was then digested with
BamHI and EcoRI and subcloned into BamHI/EcoRI digested pGEX-
2T vector. The identity and reading frame of the Fyn cDNA was
veri¢ed by DNA sequencing of the pGEX-Fyn construct.
2.5. Expression and puri¢cation of the GST-Fyn construct
Protein expression was induced with 0.1 mM IPTG for 3 h at 37‡C.
The protein was puri¢ed on a non-denaturing 10% polyacrylamide gel
from the inclusion body cell fraction. The protein band of expected
fusion protein size was then excised and electroeluted. The isolated
soluble protein was a⁄nity puri¢ed on glutathione-agarose beads and
then cleaved with thrombin at a protease:protein (w/v) ratio of 1:10
for 2 h at 25‡C with constant agitation.
2.6. Puri¢cation of GAP C2 domain complexing proteins from sheep
liver
Ca2-dependent membrane binding proteins were prepared from
sheep liver homogenates as previously described [21] and, from this
fraction, GAP C2 domain complexing proteins were a⁄nity puri¢ed
using a GSTGAP C2 domain (GSTGAP606ÿ648) fusion protein as
previously described by us [21].
2.7. Annexin VI overlay binding assay
GSTGAP C2 domain complexing proteins puri¢ed from sheep liver
as described above were eluted from glutathione-agarose beads with
15 mM free glutathione. Approximately 5 Wg of total protein was
resolved on SDS polyacrylamide gels and transferred to nitrocellulose
¢lters. Filters were then blocked overnight with phosphate bu¡ered
saline (PBS) containing 5% (w/v) skimmed milk powder followed by
their incubation in the presence or absence of 16 nM GST or GSTan-
nexin VI at 25‡C for 1 h. Bound fusion protein was detected with
anti-GST polyclonal antibodies (1/1000 v/v dilution) followed by
probing with goat anti-rabbit HRP antibodies and ECL.
2.8. Fyn overlay binding assay
300 ng of recombinant Fyn was subjected to SDS^PAGE and West-
ern transferred to nitrocellulose membranes. Membranes were blocked
with 5% (w/v) skimmed milk powder in PBS for 1 h and then incu-
bated with either 16 nM GST or 16 nM GSTannexin VI at 25‡C for
1 h. Bound fusion protein was detected with anti-GST polyclonal
antibodies followed by probing with anti-rabbit HRP antibodies
and ECL.
2.9. Transfection of COS cells with pCMV vector or pCMVPyk2 DNA
COS-1 cells were routinely diluted to approximately 20^25% con-
£uence 3^6 h prior to their transfection. For each 10 cm plate of cells
used, 4 Wg of vector (pCMV-Tag1) or pCMVPyk2 DNA [26] was pre-
incubated with 25 Wl of lipofectin in a ¢nal volume of 4 ml of Opti-
MEM medium for 15 min prior to transfection. The cells were washed
three times with serum-free Opti-MEM and incubated for 12 h with
the DNA^lipofectin mixture in a 5% CO2 atmosphere at 37‡C. The
transfection mixture was then removed and replaced with Dulbecco’s
modi¢ed Eagle’s medium containing 10% (v/v) foetal bovine serum
and the cells were incubated in a 5% CO2 atmosphere at 37‡C. Cells
were harvested for immunoprecipitation studies no more than 24 h
after transfection began, otherwise cell death was observed. Routinely
between four and six plates of cells were pooled after transfection
(approximately 2U106 cells in total) for each immunoprecipitation
sample.
2.10. Western blot detection of myc-tagged proteins in COS cell lysates
Anti-Pyk2 or anti-GAP immunoprecipitated protein complexes
from transfected COS cells were resolved by SDS^PAGE and Western
transferred to nitrocellulose ¢lters. Filters were probed with either
anti-Pyk2 (1 Wg/ml) or anti-myc (5 Wg/ml) antibodies diluted in 5%
skimmed milk/PBS solution. Bound antibodies were detected with
goat anti-rabbit HRP-conjugated antibodies (1/1000 v/v dilution) fol-
lowed by ECL.
3. Results
3.1. A⁄nity puri¢cation of the p55, p70, p120 complex using a
GTGAPC2 domain fusion protein and the identi¢cation of
p55 as an annexin VI binding protein
Our previous studies using far Western overlay assays had
indicated that the RasGAP C2 domain interacts directly with
annexin VI. However, no evidence had been obtained for the
direct interaction of this C2 domain with either p55 or p120 in
this protein complex. Thus, it was conceivable that annexin VI
could in turn be mediating a protein^protein interaction with
one or more of these proteins. So, in order to address this
question, we puri¢ed proteins complexing with the C2 domain
of RasGAP from sheep liver using a GSTGAP C2 domain
a⁄nity puri¢cation procedure as previously described by us
[21]. We then resolved samples of the complexing proteins on
SDS polyacrylamide gels (Fig. 1A) and transferred the puri-
¢ed complex proteins to nitrocellulose. The proteins were then
assayed for their ability to bind to GST or GSTannexin VI
fusion protein (Fig. 1B). We observed that the annexin VI
Fig. 1. Annexin VI binds to p55. A: Coomassie blue stained gel
showing a⁄nity puri¢ed GST and GSTGAP C2 complexing pro-
teins from sheep liver homogenates. B: Far Western overlay binding
assay demonstrates GSTannexin VI fusion protein speci¢cally bound
to p55.
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fusion protein speci¢cally bound to the complexing proteins
around the expected size for p55. Neither the anti-GST anti-
body, which was used to detect the fusion protein, or the
control GST protein was detected as binding to p55 (Fig.
1B). It was also noted that a protein band of V42 kDa is
often additionally observed by Coomassie blue staining of gels
(Fig. 1A), but since this protein is detected by annexin VI
antibodies when these samples are Western blotted, we believe
that this is a breakdown product of annexin VI (data not
shown).
Fig. 2. p55 is Fyn. A: The 55 kDa GSTGAP C2 complexing protein is speci¢cally detected with anti-Fyn antibodies. B: Coomassie stained
SDS polyacrylamide gel showing puri¢ed recombinant Fyn (V59 kDa) and GST (27 kDa) after cleavage of GSTFyn with thrombin. C: Anti-
Fyn antibodies detect recombinant cleaved GSTFyn, but not GST control protein. D: Far Western overlay binding assay demonstrates GSTan-
nexin VI, but not GST, binds to recombinant Fyn protein. E: GAP and F: annexin VI are detected in anti-GAP and anti-Fyn but not pre-im-
mune serum control immunoprecipitates from Rat-1 ¢broblast cell lysates.
Fig. 3. Evidence that p120 is the proline rich tyrosine kinase Pyk2. A: Anti-Pyk2 antibodies speci¢cally detect the 120 kDa GSTGAP C2 com-
plexing protein. B: Con¢rmation of Pyk2 expression and GAP co-immunoprecipitation of Pyk2 in pCMV or pCMVPyk2 transfected COS cells.
C: Anti-Myc antibodies detect Myc tagged Pyk2 protein from anti-GAP immunoprecipitates of pCMVPyk2, but not pCMV, transfected COS
cells.
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3.2. Identi¢cation of p55 as Fyn
In order to identify p55, proteins that had a similar appar-
ent molecular weight and had previously been shown to in-
teract with annexin VI were ¢rst considered. The Src family
kinase Lck thus became a prime candidate since it has a
molecular weight of 56 kDa and has been shown to interact
with annexin VI in T cells [22]. However, Lck is predomi-
nantly expressed in lymphocytes and since we had observed
reasonably high levels of p55 complexing with GAP in liver
we reasoned that it was improbable that p55 was Lck. How-
ever, because Src family kinases are known to play an impor-
tant role in the activation of the Ras signalling pathway and
often have been demonstrated to functionally compensate for
each other in cellular systems, we considered the possibility
that p55 could be another Src family kinase. The protein Fyn
has a molecular weight of 59 kDa (also a 56 kDa splice var-
iant has been detected in some cell types), is a Src family
kinase and displays a wide tissue expression pro¢le [23].
Thus we tested the possibility that p55 could be Fyn. Western
blots containing the GAP GSTC2 domain interacting proteins
puri¢ed from sheep liver were probed with anti-Fyn antibod-
ies and the presence of Fyn was indeed detected (Fig. 2A). In
addition, the antibody was very speci¢c since it only detected
a protein of the expected V55 kDa size even though this
protein is not the most abundant protein in the protein com-
plex (Fig. 1A). To further verify the identity of p55, puri¢ed
recombinant Fyn was expressed as a GST fusion protein in
Escherichia coli. The fusion protein was cleaved from the GST
sequence to liberate soluble Fyn protein (Fig. 2B) and the
identity of the recombinant Fyn protein was con¢rmed by
Western blot analysis using anti-Fyn antibodies (Fig. 2C).
Using this cleaved fusion protein in an overlay binding assay
with GST control and GSTannexin VI fusion proteins we
con¢rmed that annexin VI was indeed able to speci¢cally
bind to recombinant Fyn (Fig. 2D). Next, in order to test
whether Fyn could co-complex with GAP and annexin VI
in a mammalian cell system, we immunoprecipitated Fyn
from Rat-1 ¢broblast cell lysates using our anti-Fyn polyclon-
al antibody and anti-GAP and pre-immune serum antibodies
as positive and negative controls respectively. After resolving
immunoprecipitated proteins on SDS polyacrylamide gels, we
¢rstly probed Western blots for the presence of RasGAP (Fig.
2E) and then re-probed for the presence of annexin VI (Fig.
2F). We were able to clearly detect both RasGAP and annexin
VI as co-complexing in these anti-Fyn immunoprecipitated
samples. Therefore, p55 is Fyn and it can interact with annex-
in VI to form a protein complex with GAP when annexin VI
and RasGAP are interacting in cellular systems.
3.3. Identi¢cation of p120 as the proline rich tyrosine kinase
Pyk2
We next reasoned that p120 could be a Fyn binding protein
and thus have the ability to form a protein complex with
annexin VI and RasGAP. Since a range of Src family kinases
are known to interact with the focal adhesion kinase (FAK)
family member Pyk2 in a Ca2-dependent manner and Pyk2
has an apparent molecular weight of 110^125 kDa [24,25], we
considered the possibility that p120 could be Pyk2. To test
this, using anti-Pyk2 antibodies and Western blotting, we
¢rstly probed for the presence of Pyk2 in the GSTGAP C2
domain complexing proteins puri¢ed from sheep liver and
were clearly and speci¢cally able to detect Pyk2 (Fig. 3A).
Next, in order to eliminate the possibility that our anti-Pyk2
antibody could be cross-reacting with the related kinase FAK
(even though our antibody is raised to the stretch of amino
acids corresponding to residues 726^863 of human Pyk2
which is uniquely found in Pyk2) we checked the speci¢city
of our antibody. To do this, we transfected COS cells with the
Fig. 4. Pyk2 simultaneously complexes with GAP and annexin VI in Rat-1 ¢broblast cell lysates. A: Anti-GAP antibodies speci¢cally co-immu-
noprecipitate Pyk2. B: Anti-Pyk2 antibodies speci¢cally co-immunoprecipitate GAP. C: Anti-Pyk2 antibodies speci¢cally co-immunoprecipitate
annexin VI.
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mammalian expression vector pcmv containing cDNA encod-
ing Rat Pyk2, which contained an N-terminal myc epitope tag
[26]. Using our anti-Pyk2 antibodies, and anti-GAP antibod-
ies, we were able to immunoprecipitate and Western blot de-
tect the heterologously expressed Pyk2 from pcmvPyk2 but
not from pcmv vector control transfected cells (Fig. 3B). Sim-
ilarly by anti-GAP immunoprecipitation and anti-myc West-
ern blot detection we were able to demonstrate that GAP was
indeed co-immunoprecipitating with the myc-tagged Pyk2
protein (Fig. 3C). Thus, p120 is Pyk2 and it can co-complex
in COS cells with RasGAP.
3.4. Co-immunoprecipitation studies in Rat-1 ¢broblasts; Pyk2
forms a complex with RasGAP and annexin VI in
mammalian cells
Finally, we looked for evidence for the co-complexing of
Pyk2 with GAP and annexin VI in rat ¢broblasts (Fig. 4). By
immunoprecipitating complexed proteins with either anti-
GAP antibodies (Fig. 4A), or anti-Pyk2 antibodies (Fig.
4B,C) we were indeed able to detect the presence of Pyk2 in
a complex with RasGAP and annexin VI in cell lysates.
4. Discussion
In this study we have successfully identi¢ed the proteins p55
and p120 which were previously shown to form a protein
complex with the p120GAP C2 domain [21]. Our rationale
was to identify these proteins in order to obtain clues as to
the signalling functions of annexin VI and RasGAP. From
our studies presented here and our previous work [21,27] we
conclude that the C2 domain interacts with annexin VI, which
in turn interacts with Fyn. Thus, annexin VI appears to be a
‘bridging’ protein for protein complex formation. We specu-
late that Pyk2 in turn may interact with Fyn since others have
shown that a range of Src family kinases have been identi¢ed
as co-complexing with Pyk2 [28,29]. Also, a Src SH2 domain
binding site has been identi¢ed as a tyrosine residue (Y402) in
rat Pyk2 [28].
Since Fyn and Pyk2 are both important tyrosine kinases
associated with the regulation of p21 Ras proteins, and C2
domains have been proposed to function as Ca2 sensors in
signalling proteins [30] we can at this stage only speculate that
the signalling role of this protein complex may well be inti-
mately linked with a Ca2 mediated regulation of p21 Ras
activity. Certainly, other workers have demonstrated that el-
evation of intracellular Ca2 levels either by ionophore treat-
ment or by stimulation of GPCRs coupled to PLC-L activa-
tion via Gq or Gi proteins can result in Ras [4] and MAP
kinase [24,31,32] activations. Hence, this novel protein com-
plex may have a role to play in the convergence of tyrosine
kinase and G protein coupled receptor/Ca2 signalling path-
ways to Ras. The elucidation of the signalling role of this
protein complex will be the subject of our future work, as
will the more detailed investigation of the interaction mecha-
nisms and mapping of sites of interactions within these pro-
teins.
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